PIONEERING SINGLE-CELL TECHNOLOGIES

Fluicell is an innovative life science company dedicated to providing single-cell microfluidic research tools and services for scientists worldwide. We deliver easy-to-use solutions for your research needs in single-cell biology, electrophysiology, single-cell bioprinting and tissue modelling.

Proposed mechanism for protocell formation on early earth

Primitive protocells, formed from surface-associated lipid material, is proposed to be an early progenitor to the biological cell….

Read more
12 Aug 2020

Single-cell analysis of CXCR4 Receptor signaling

Chemokine receptors are important components in sell signaling, fulfilling a wide range of biological functions. In the paper…

Read more
03 Jul 2020

Warrant series TO1 fully subscribed

Today, Fluicell announce that the warrant series TO 1, which ended on June 22, has been fully subscribed….

Read more
25 Jun 2020

What our customers say

“The BioPen System is one of the best single-cell treatment system on the market. It is easy-to-use, and gives me beautiful, publication-ready movies.”

Dr. Dani Cai from the National Institutes of Health

“The Dynaflow Resolve System is the most easy to use, and robust, perfusion system available for whole cell patch-clamp recordings of isolated cells. “

Prof. Kent Jadermark from Karolinska Institutet

“The BioPen system provide us with unique data with it you are able to see how cell process are trapped.”

Prof. Rizzo from the University of Maryland Medical Center

“After several years of use, we are satisfied with the Dynaflow Resolve system. It provides reliable and fast solution exchange.”

Gedeon Richter plc

“The BioPen system allows us to save money on expensive drugs because it uses very small amounts.”

U.S. Food and Drug Administration

“The Dynaflow Resolve system is a very reliable and efficient tool for automated compound application with excellent performance in fast solution exchange.

Dr. Timm Danker from NMI TT

“I chose the BioPen System because I can target precise areas of the cell. Consumption of expensive antibodies and drugs is minimized compared to perfusion of the whole cell as we used to have to do.”

Dr. Joseph Bruton from Karolinska Institutet

«The BioPen product is well designed and works even better than we could have hoped. The team is very reliable with customer support. I would highly recommend purchasing this product.»

Veronica Jove from the Rockefeller University

«For the application of expensive substances or small amounts of reagents, it’s challenging to use perfusion systems. Using the BioPen System allows us now to precisely perfuse only few single cells and record their subsequent reactions and metabolic changes.»

Roland Malli's Lab from Medical University of Graz